Altri SGPS SA

ALSS.LS

$5.52

Closing

▲1.08%

1D

▲12.07%

YTD

Market cap

$1.13B

52 week high

$5.71

52 week low

$4.20

Volume

392,762

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $3.99/month

Market cap

$1.13B

Analysts' Rating

BUY

Price Target (Mean)

0.00

Total Analysts

1

P/E

24.71

Operating Margin

-0.63%

Beta

1.13

Revenue Growth (Annual)

-

52 week high

$5.71

52 week low

$4.20

Div. Yield

4.90%

EPS Annual Growth

-100.00

Note on Purification and Zakat

  • Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly). 
  • If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
  • For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them. 

Company Profile

Altri SGPS SA (Altri) is a Portugal-based holding company primarily involved in the production of bleached paper pulp from eucalyptus. The Company is also present in electric energy from forest renewable sources, namely industrial cogeneration from black liquor and biomass. Additionally, it is engaged in activity of the management of investments. The Company operates through a numerous subsidiaries, which are active in the production and sale of paper pulp, such as Caima – Industria de Celulose SA, Celbi – Celulose da Beira Industrial SA and Celtejo – Empresa de Celulose do Tejo SA and as various subsidiaries active in the management of forest resources, including Altri Florestal SA, as well as joint venture of EDP Bioelectrica, among others.